SEC Form 4 · accession 0001144204-15-010774

SANGAMO THERAPEUTICS, INC · SGMO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners

Other

Other

Other

Period of report

Jan 29, 2014

Accepted (ET)

Feb 18, 2015 · 9:51 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001001233

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F3,F1	Mar 6, 2014	S	40,482	$24.095	D	3,683,000	D
Common Stock^F3,F1	Mar 6, 2014	S	21,001	$24.10	D	3,683,000	D
Common Stock^F2,F1	Mar 7, 2014	P	258,377	$22.2487	A	3,683,000	D
Common Stock^F2,F1	Mar 10, 2014	P	12,522	$22.2952	A	3,683,000	D
Common Stock^F3,F1	Mar 12, 2014	S	123,480	$23.40	D	3,683,000	D
Common Stock^F2,F1	Mar 13, 2014	P	71,319	$22.7619	A	3,683,000	D
Common Stock^F2,F1	Mar 17, 2014	P	52,161	$23.0217	A	3,683,000	D
Common Stock^F3,F1	Mar 18, 2014	S	34,440	$23.7448	D	3,683,000	D
Common Stock^F3,F1	Mar 18, 2014	S	49,560	$23.745	D	3,683,000	D
Common Stock^F3,F1	Mar 19, 2014	S	17,808	$24.283	D	3,683,000	D
Common Stock^F2,F1	Mar 21, 2014	P	101,808	$21.2163	A	3,683,000	D
Common Stock^F1	Mar 25, 2014	P	21,000	$19.33	A	3,704,000	D
Common Stock^F1	Mar 25, 2014	P	42,000	$19.4418	A	3,746,000	D
Common Stock^F1	Mar 25, 2014	P	21,000	$19.455	A	3,767,000	D
Common Stock^F1	Mar 26, 2014	P	19,320	$17.875	A	3,786,320	D
Common Stock^F1	Mar 26, 2014	P	190,693	$18.162	A	3,977,013	D
Common Stock^F1	Mar 27, 2014	P	4,200	$17.35	A	3,981,213	D
Common Stock^F1	Mar 27, 2014	P	251,987	$17.6576	A	4,233,200	D
Common Stock^F1	Mar 28, 2014	P	21,840	$17.07	A	4,255,040	D
Common Stock^F1	Mar 28, 2014	P	62,160	$17.105	A	4,317,200	D
Common Stock^F1	Apr 1, 2014	S	48,500	$17.8751	D	4,268,700	D
Common Stock^F1	Apr 1, 2014	S	24,900	$17.885	D	4,243,800	D
Common Stock^F1	Apr 1, 2014	S	50,000	$17.945	D	4,193,800	D
Common Stock^F1	Apr 1, 2014	S	51,500	$18.076	D	4,142,300	D
Common Stock^F1	Apr 1, 2014	S	75,100	$18.135	D	4,067,200	D

No Table II lines on this filing.

F1The reported securities are owned by RA Capital Healthcare Fund, L.P. (the "Fund"). RA Capital Management, LLC (the "Adviser") is the general partner of the Fund, and Peter Kolchinsky is the sole manager of the Adviser. The Adviser and Mr. Kolchinsky disclaim beneficial ownership of the reported securities in reliance on Rule 16a-1(a)(1)(v) and (vii), respectively, and therefore disclaim any obligation to report ownership of the reported securities other than on behalf of the Fund. The filing of this Form 4 shall not be construed as an admission that either the Adviser or Mr. Kolchinsky is or was, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of any of the securities reported herein. The number of shares reported in Col 5 of Table I and the number of options reported in Col 9 of Table II reflect the number of shares or options, as applicable, beneficially owned by the Fund as of the time of the last transaction reported herein.
F2The Fund delivered these shares to a stock lender to satisfy the Fund's obligation to return shares previously borrowed.
F3The Fund borrowed shares for delivery against this sale.